Abbott Laboratories PE Ratio 2006-2018 | ABT

Current and historical p/e ratio for Abbott Laboratories (ABT) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Abbott Laboratories PE ratio as of December 12, 2018 is 25.81.
Abbott Laboratories PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-12-12 72.53 151.10
2018-09-30 73.36 $0.48 152.83
2018-06-30 60.72 $0.50 121.44
2018-03-31 59.37 $0.25 237.48
2017-12-31 56.28 $0.26 216.46
2017-09-30 52.37 $1.27 41.23
2017-06-30 47.45 $0.71 66.83
2017-03-31 43.08 $0.96 44.88
2016-12-31 37.03 $0.93 39.81
2016-09-30 40.51 $0.91 44.51
2016-06-30 37.42 $1.51 24.78
2016-03-31 39.58 $1.62 24.43
2015-12-31 42.23 $2.92 14.46
2015-09-30 37.60 $3.00 12.53
2015-06-30 45.66 $2.98 15.32
2015-03-31 42.88 $2.76 15.54
2014-12-31 41.44 $1.49 27.81
2014-09-30 38.08 $1.27 29.99
2014-06-30 37.25 $1.52 24.51
2014-03-31 34.87 $1.52 22.94
2013-12-31 34.51 $1.62 21.30
2013-09-30 29.76 $1.91 15.58
2013-06-30 31.15 $2.51 12.41
2013-03-31 31.43 $3.29 9.55
2012-12-31 27.89 $3.73 7.48
2012-09-30 29.09 $4.09 7.11
2012-06-30 27.25 $3.07 8.88
2012-03-31 25.80 $3.22 8.01
2011-12-31 23.57 $2.99 7.88
2011-09-30 21.34 $2.89 7.39
2011-06-30 21.87 $3.27 6.69
2011-03-31 20.29 $2.87 7.07
2010-12-31 19.73 $2.96 6.67
2010-09-30 21.43 $3.02 7.10
2010-06-30 19.11 $3.40 5.62
2010-03-31 21.43 $3.40 6.30
2009-12-31 21.89 $3.68 5.95
2009-09-30 19.98 $3.68 5.43
2009-06-30 18.92 $3.42 5.53
2009-03-31 19.10 $3.44 5.55
2008-12-31 21.30 $3.12 6.83
2008-09-30 22.90 $2.91 7.87
2008-06-30 21.00 $2.68 7.84
2008-03-31 21.79 $2.46 8.86
2007-12-31 22.13 $2.31 9.58
2007-09-30 21.07 $1.23 17.13
2007-06-30 20.98 $1.23 17.06
2007-03-31 21.80 $1.00 21.80
2006-12-31 18.98 $1.11 17.10
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $127.387B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $128.543B 19.22
Stryker (SYK) United States $64.588B 24.35
Boston Scientific (BSX) United States $51.339B 25.94
Baxter (BAX) United States $35.653B 23.02
Zimmer Biomet Holdings (ZBH) United States $23.039B 14.94
Smith & Nephew SNATS (SNN) United Kingdom $16.882B 0.00
ResMed (RMD) United States $16.410B 31.29
Perrigo (PRGO) Ireland $7.997B 12.14
Bio-Rad Laboratories (BIO) United States $7.618B 48.71
Canopy Growth (CGC) Canada $7.436B 0.00
Hill-Rom Holdings (HRC) United States $6.496B 20.32
Aurora Cannabis (ACB) Canada $6.099B 32.21
Haemonetics (HAE) United States $5.365B 47.18
Insulet (PODD) United States $4.925B 0.00
ICU Medical (ICUI) United States $4.805B 26.77
Hutchison China MediTech (HCM) China $4.419B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.779B 0.00
Neogen (NEOG) United States $3.367B 50.98
Agios Pharmaceuticals (AGIO) United States $3.261B 0.00
NuVasive (NUVA) United States $2.912B 27.09
National Vision Holdings (EYE) United States $2.458B 47.55
Quidel (QDEL) United States $2.024B 26.39
NxStage Medical (NXTM) United States $1.918B 0.00
Aphria (APHA) $1.451B 0.00
Phibro Animal Health (PAHC) United States $1.321B 18.70
AtriCure (ATRC) United States $1.188B 0.00
Cardiovascular Systems (CSII) United States $1.021B 1469.50
VAREX IMAGING (VREX) United States $0.937B 18.76
PetIQ (PETQ) United States $0.858B 22.23
Surmodics (SRDX) United States $0.786B 119.80
Cerus (CERS) United States $0.780B 0.00
Meridian Bioscience (VIVO) United States $0.778B 24.78
OraSure Technologies (OSUR) United States $0.747B 42.07
Omeros (OMER) United States $0.703B 0.00
Lantheus Holdings (LNTH) United States $0.670B 20.75
Eagle Pharmaceuticals (EGRX) United States $0.661B 21.21
MacroGenics (MGNX) United States $0.605B 0.00
NanoString Technologies (NSTG) United States $0.536B 0.00
LeMaitre Vascular (LMAT) United States $0.514B 25.24
Quanterix (QTRX) United States $0.438B 0.00
Owens & Minor (OMI) United States $0.428B 4.84
TG Therapeutics (TGTX) United States $0.423B 0.00
Insys Therapeutics (INSY) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.331B 21.40
Evolus (EOLS) United States $0.327B 0.00
VAPOTHERM INC (VAPO) United States $0.307B 0.00
Cytosorbents (CTSO) United States $0.282B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.241B 0.00
Surface Oncology (SURF) United States $0.238B 0.00
Bovie Medical (BVX) United States $0.236B 0.00
BioLife Solutions (BLFS) United States $0.222B 300.25
Rockwell Medical (RMTI) United States $0.182B 0.00
Chimerix (CMRX) United States $0.172B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.142B 0.00
Fonar (FONR) United States $0.136B 6.83
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.81
Female Health (VERU) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 17.93
CAS Medical Systems (CASM) United States $0.053B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.030B 0.00
Myomo (MYO) United States $0.023B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00